Chart calendar Jazz Pharmaceuticals plc

a5ad69a2555a1c2ff731bd79dbd477.vTlkvfulwCgoGkReQVn0WusNu7vx8IBjSXA4NoBMcWU.zXMA-6LClhhGQigbO2m7btps7u2WivIoPyROaeYfSFPSXAiOguP5GRlQBQ~9e845dc3bd997ebe42c2fe2f2ac179fe

Upcoming events on Jazz Pharmaceuticals plc

2026-01-08

American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract # LBA285

2026-01-09

American Society of Clinical Oncology Gastrointestinal Cancers Symposium

2026-01-09

American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract # 545

2026-03-02

Q4 2025 Earnings Release (Projected)

2026-05-11

Q1 2026 Earnings Release (Projected)

2026-08-10

Q2 2026 Earnings Release (Projected)

2026-11-10

Q3 2026 Earnings Release (Projected)

Past events on Jazz Pharmaceuticals plc

2025-12-02

Citi Global Healthcare Conference

2025-11-23

Society for Neuro-Oncology Meeting - Oral Abstract No:DDDR-38

2025-11-22

Society for Neuro Oncology Meeting - Poster No:EXTH-70

2025-11-22

Society for Neuro Oncology Meeting - Poster No:TMET-26

2025-11-21

Society for Neuro Oncology Meeting - Poster No:CTP-15

2025-11-21

Society for Neuro Oncology Meeting - Oral Abstract No:TMET-51

2025-11-05

Q3 2025 Earnings Call

2025-11-05

Q3 2025 Earnings Release

2025-09-03

Wells Fargo Healthcare Conference - Fireside Chat

2025-08-27

Modeyso™ (dordaviprone) FDA Approval Call

2025-08-05

Q2 2025 Earnings Call

2025-08-05

Q2 2025 Earnings Release

2025-07-24

Annual General Meeting

2025-06-11

Associated Professional Sleep Societies Meeting

2025-06-11

Associated Professional Sleep Societies Meeting - Poster No : 418

2025-06-11

Associated Professional Sleep Societies Meeting - Poster No : 420

2025-06-11

Associated Professional Sleep Societies Meeting - Poster No : 415

2025-06-11

Associated Professional Sleep Societies Meeting - Poster N0 : 424

2025-06-11

Associated Professional Sleep Societies Meeting - Poster No : 414

2025-06-11

Associated Professional Sleep Societies Meeting - Poster No : 422

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
3 659
3 665
-0.15%
3 834
3 832
0.06%
4 069
4 041
0.7%

4 230


4 517


4 847

EBITDA
Million USD
Released
Forecast
Spread
1 338
1 473
-9.16%
1 681
1 739
-3.36%
1 760
1 749
0.61%

611


1 815


1 941

EBIT
Million USD
Released
Forecast
Spread
1 307
1 400
-6.63%
1 650
1 682
-1.85%
1 727
1 726
0.05%

650


1 852


1 993

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-373
47,8
-880.03%
298
379
-21.44%
470
476
-1.22%

-668


610


844

Net income
Million USD
Released
Forecast
Spread
-224
-66,2
-238.34%
415
519
-20.02%
560
523
7.14%

-411


529


803

EPS
USD
Released
Forecast
Spread
-3,58
-1,84
-94.67%
6,10
7,53
-18.97%
8,65
8,11
6.63%

-6,32


7,72


12,3

Announcement Date01/03/2328/02/2425/02/25-

Quarterly results

Fiscal PeriodSeptember 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million USD
Released
Forecast
Spread
902
954
-5.48%
1 024
1 004
2.02%
1 055
1 037
1.78%
1 088
1 058
2.84%
898
984
-8.73%
1 046
1 047
-0.14%
1 126
1 109
1.58%

1 156


977


1 092


1 138


1 201

EBITDA
Million USD
Released
Forecast
Spread
320
390
-17.96%
452
431
5.03%
520
465
11.92%
467
477
-2.15%
207
418
-50.56%
-401
-411
2.43%
380
480
-20.71%

507













EBIT
Million USD
Released
Forecast
Spread
312
389
-19.73%
445
430
3.29%
512
453
13.16%
458
461
-0.68%
196
391
-49.82%
-413
-356
-16.11%
370
481
-23.03%

493


413


488


522


540

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-1,60
73,4
-102.18%
138
99,1
39.22%
201
139
44.79%
133
149
-10.72%
-110
81,0
-235.5%
-736
-476
-54.42%
9,04
164
-94.49%

160


43,1


128


153


204

Net income
Million USD
Released
Forecast
Spread
-14,6
85,3
-117.15%
169
108
55.88%
215
151
42.36%
191
168
13.76%
-92,5
81,2
-214%
-718
-521
-37.88%
251
164
53.67%

164


42,6


122


146


194

EPS
USD
Released
Forecast
Spread
-0,23
1,07
-121.53%
2,49
1,45
72.09%
3,42
2,20
55.63%
3,11
2,71
14.81%
-1,52
1,44
-205.69%
-11,7
-7,13
-64.65%
4,08
2,54
60.91%

2,61


0,69


1,98


2,35


3,13

Announcement Date01/05/2431/07/2406/11/2425/02/2506/05/2505/08/2505/11/25-----
2025-12-08

Q2 2026 Earnings Release

2026-01-07

Q3 2026 Earnings Release (Projected)

2026-01-11

Q2 2026 Earnings Release (Projected)

2026-01-15

Q3 2026 Earnings Release (Projected)

2026-01-20

Q4 2025 Earnings Release

2026-01-20

Q4 2025 Earnings Release (Projected)

2026-01-21

Q3 2026 Earnings Release (Projected)

2026-01-21

Q3 2026 Earnings Release (Projected)

2026-01-21

Q3 2026 Earnings Release (Projected)

2026-01-22

Q3 2026 Earnings Release (Projected)

More events

Past sector events for Jazz Pharmaceuticals plc

2025-11-30

Q3 2025 Earnings Release

2025-11-27

Q2 2026 Earnings Release

2025-11-19

Q3 2025 Earnings Release

2025-11-14

Q2 2026 Earnings Release

2025-11-14

Q2 2026 Earnings Release

2025-11-14

Q3 2025 Earnings Release

2025-11-13

Q3 2025 Earnings Release

2025-11-13

Q3 2025 Earnings Release

2025-11-13

Q3 2025 Earnings Release

2025-11-13

Q2 2025 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. JAZZ Stock
  4. Calendar Jazz Pharmaceuticals plc